Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARCADIA Trial of AZD1656 in hospitalized diabetic patients with suspected or confirmed COVID-19
2020-002211-21Phase 2Unknown
- Sponsor
- St George Street Capital
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing AZD1656 with Placebo (2 arms). Primary endpoint: Clinical improvement at Day 14. Status: unknown.
02
Drugs
AZD1656
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-002211-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002211-21.